Together with the in vitro assays (Figure 4C–F, Figure 4—figure supplement 1A–C), we propose that cholesterol clearance systems, particularly ACATs, can be used as molecular targets to selectively inhibit the growth of Snail-positive cancers. The gene discussed is SNAI1; the disease is cancer.